Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Ezeprogind
2. Azp-2006 Free Base
3. Tr9yq07eln
4. 615539-20-3
5. Asp2006 Free Base
6. Unii-tr9yq07eln
7. Chembl419432
8. 615539-20-3 (free Base)
9. N-[3-[4-[3-[bis(2-methylpropyl)amino]propyl]piperazin-1-yl]propyl]-1h-benzimidazol-2-amine
10. N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1h-benzo[d]imidazol-2-amine
11. Ezeprogind [inn]
12. Azp2006 Free Base
13. Schembl2444189
14. Klkkwcpjbtxwov-uhfffaoysa-n
15. Bdbm50134471
16. Akos040758235
17. Hy-109172
18. (1h-benzoimidazol-2-yl)-{3-[4-(3-diisobutylamino-propyl)-piperazin-1-yl]-propyl}-amine
19. {3-[4-(3-diisobutylamino-propyl)-piperazin-1-yl]-propyl}-(1h-benzimidazol-2-yl)-amine
20. 1,4-piperazinedipropanamine, N'-1h-benzimidazol-2-yl-n,n-bis(2-methylpropyl)-
21. 1,4-piperazinedipropanamine, N4-1h-benzimidazol-2-yl-n1,n1-bis(2-methylpropyl)-
22. N4-1h-benzimidazol-2-yl-n1,n1-bis(2-methylpropyl)-1,4-piperazinedipropanamine
| Molecular Weight | 428.7 g/mol |
|---|---|
| Molecular Formula | C25H44N6 |
| XLogP3 | 5.1 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 13 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 50.4 |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 467 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Treatment of progressive supranuclear palsy
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
30
PharmaCompass offers a list of Ezeprogind API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ezeprogind manufacturer or Ezeprogind supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ezeprogind manufacturer or Ezeprogind supplier.
PharmaCompass also assists you with knowing the Ezeprogind API Price utilized in the formulation of products. Ezeprogind API Price is not always fixed or binding as the Ezeprogind Price is obtained through a variety of data sources. The Ezeprogind Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ezeprogind manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ezeprogind, including repackagers and relabelers. The FDA regulates Ezeprogind manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ezeprogind API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Ezeprogind supplier is an individual or a company that provides Ezeprogind active pharmaceutical ingredient (API) or Ezeprogind finished formulations upon request. The Ezeprogind suppliers may include Ezeprogind API manufacturers, exporters, distributors and traders.
Ezeprogind Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ezeprogind GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ezeprogind GMP manufacturer or Ezeprogind GMP API supplier for your needs.
A Ezeprogind CoA (Certificate of Analysis) is a formal document that attests to Ezeprogind's compliance with Ezeprogind specifications and serves as a tool for batch-level quality control.
Ezeprogind CoA mostly includes findings from lab analyses of a specific batch. For each Ezeprogind CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ezeprogind may be tested according to a variety of international standards, such as European Pharmacopoeia (Ezeprogind EP), Ezeprogind JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ezeprogind USP).
